Post by Medical Toxicology

New Data on Injectable Buprenorphine for High-Risk OUD Patients A 24-week observational study from Vancouver, Canada, evaluated extended-release injectable buprenorphine (XR-BUP) in individuals at high risk of opioid overdose. While XR-BUP was well tolerated and safe, only 32% completed the full 6-month course, and opioid-free rates remained low during treatment. 📌 Key findings: 92% had prior overdose history 76% were using fentanyl at baseline Median injections received: 2 No serious adverse events reported ⚠️ Retention challenges persist in real-world, low-barrier settings. 🔗 Read the full study and insights on the future of XR-BUP for vulnerable populations: https://lnkd.in/gChty5gP 📚 Stay informed: Read this and the most up-to-date research in medical toxicology every day at MedicalToxic.com #AddictionMedicine #OUD #Buprenorphine #HarmReduction #OpioidCrisis #MedicalToxicology #FASTERBUP #XRBuprenorphine #PublicHealth